Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 1;10(5):715.
doi: 10.3390/antiox10050715.

Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease

Affiliations

Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease

Emilio Fernández-Espejo et al. Antioxidants (Basel). .

Abstract

Background. Salivary α-synuclein (aSyn) and its nitrated form, or 3-nitrotyrosine-α-synuclein (3-NT-αSyn), hold promise as biomarkers for idiopathic Parkinson's disease (IPD). Nitrative stress that is characterized by an excess of 3-nitrotyrosine proteins (3-NT-proteins) has been proposed as a pathogenic mechanism in IPD. The objective is to study the pathological role of native αSyn, 3-NT-αSyn, and 3-NT-proteins in the saliva and submandibulary glands of patients with IPD. Methods. The salivary and serum αSyn and 3-NT-proteins concentration is evaluated with ELISA in patients and controls. Correlations of αSyn and 3-NT-proteins content with clinical features of the disease are examined. Immunohistochemical 3-NT-αSyn expression in submandibulary gland sections is analyzed. Results. (a) Salivary concentration and saliva/serum ratios of native αSyn and 3-NT-proteins are similar in patients and controls; (b) salivary αSyn and 3-NT-proteins do not correlate with any clinical feature; and (c) three patterns of 3-NT-αSyn-positive inclusions are observed on histological sections: rounded "Lewy-type" aggregates of 10-25 µm in diameter, coarse deposits with varied morphology, and spheroid inclusions or bodies of 3-5 µm in diameter. "Lewy-type" and coarse inclusions are observed in the interlobular connective tissue of the gland, and small-sized bodies are located within the cytoplasm of duct cells. "Lewy-type" inclusions are only observed in patients, and the remaining patterns of inclusions are observed in both the patients and controls. Conclusions. The patients' saliva presents a similar concentration of native αSyn and 3-nitrotyrosine-proteins than that of the controls, and no correlations with clinical features are found. These findings preclude the utility of native αSyn in the saliva as a biomarker, and they indicate the absence of nitrative stress in the saliva and serum of patients. As regards nitrated αSyn, "Lewy-type" inclusions expressing 3-NT-αSyn are observed in the patients, not the controls-a novel finding that suggests that a biopsy of the submandibulary gland, if proven safe, could be a useful technique for diagnosing IPD. Finally, to our knowledge, this is also the first description of 3-NT-αSyn-immunoreactive intracytoplasmic bodies in cells that are located outside the nervous system. These intracytoplasmic bodies are present in duct cells of submandibulary gland sections from all subjects regardless of their pathology, and they can represent an aging or involutional change. Further immunostaining studies with different antibodies and larger samples are needed to validate the data.

Keywords: lewy-type; nitration; nitrative stress; parkinson; saliva; α-synuclein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Individual total αSyn concentration (pg/mL) in (A) saliva and (B) serum in patients with IPD and control participants, as measured with ELISA. Mean and standard deviation are represented with solid lines. Abbrev.: αSyn, α-synuclein; IPD, idiopathic Parkinson’s disease; ELISA, enzyme-linked immunosorbent assay.
Figure 2
Figure 2
Individual 3-NT-proteins concentration (µg/mL) in (A) saliva and (B) serum in patients with IPD and control participants, as measured with ELISA. Mean and standard deviation are represented with solid lines. Abbrev.: 3-NT-proteins, 3-nitrotyrosine proteins; IPD, idiopathic Parkinson’s disease; ELISA, enzyme-linked immunosorbent assay.
Figure 3
Figure 3
Representative photomicrographs of submandibulary gland sections in patients with idiopathic Parkinson’s disease and controls, after immunostaining against 3-NT-αSyn (brown color) and IYD (grey color), or against 3-NT-αSyn alone (dark grey). (ac) Rounded “Lewy-type” inclusions of 10–25 µm in diameter are observed in the interlobular connective tissue (white arrows). These inclusions are surrounded by a halo (a) or radiating fibrils (b,c). “Lewy-type” inclusions are observed in patients, not in controls. (di) 3-NT-αSyn-positive coarse inclusions are observed within the interlobular tissue, many of them close to duct cells (black arrows). Ribbon-like, spindle-like, and ovoid deposits are seen. (c,il) 3-NT-αSyn-immunoreactive spheroid bodies of 3–5 µm in diameter are observed in the cytoplasm of duct cells (yellow arrows). High-magnification images of intracytoplasmic bodies are seen in (,,). Bodies are observed in the patients and controls. (m) Low-magnification and double-stained image of a submandibulary gland section showing main cell types (1, interlobular connective tissue; 2, acini with IYD-negative cells; 3, ducts with IYD-positive cells; 4, adipocytes). Abbrev.: 3-NT-αSyn, 3-nitrotyrosine α-synuclein; IYD, iodotyrosine deiodinase; PD, Parkinson´s disease; CT, control gland. Bars: 10 µm in (al); 5 µm in (,,); 50 µm in m.

Similar articles

Cited by

References

    1. Devic I., Hwang H., Edgar J.S., Izutsu K., Presland R., Pan C., Goodlett D.R., Wang Y., Armaly J., Tumas V., et al. Salivary α-synuclein and DJ-1: Potential biomarkers for Parkinson’s disease. Brain. 2011;134:e178. doi: 10.1093/brain/awr015. - DOI - PMC - PubMed
    1. Stewart T., Sui Y.T., Gonzalez-Cuyar L.F., Wong D.T., Akin D.M., Tumas V., Aasly J., Ashmore E., Aro P., Ginghina C., et al. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson’s disease from control. Neurobiol. Aging. 2014;35:418–420. doi: 10.1016/j.neurobiolaging.2013.08.008. - DOI - PMC - PubMed
    1. Kang W., Chen W., Yang Q., Zhang L., Zhang L., Wang X., Dong F., Zhao Y., Chen S., Quinn T.J., et al. Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients. Sci. Rep. 2016;6:28143. doi: 10.1038/srep28143. - DOI - PMC - PubMed
    1. Vivacqua G., Latorre A., Suppa A., Nardi M., Pietracupa S., Mancinelli R., Fabbrini G., Colosimo C., Gaudio E., Berardelli A. Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease. PLoS ONE. 2016;11:e0151156. doi: 10.1371/journal.pone.0151156. - DOI - PMC - PubMed
    1. Vivacqua G., Suppa A., Mancinelli R., Belvisi D., Fabbrini A., Costanzo M., Formica A., Onori P., Fabbrini G., Berardelli A. Salivary alpha-synuclein in the diagnosis of Parkinson’s disease and Progressive Supranuclear Palsy. Parkinsonism Relat. Disord. 2019;63:143–148. doi: 10.1016/j.parkreldis.2019.02.014. - DOI - PubMed